Antimicrobial resistance poses a grave threat to human health.
1 Efforts to control the emergence and spread of drug-resistant organisms depend on rapid detection and effective treatment of cases combined with epidemiologic investigations and public health interventions to prevent ongoing transmission. Laboratory support for these activities begins with the detection, identification, and antimicrobial susceptibility testing of a pathogen, which are usually performed in a local diagnostic microbiology laboratory. For a minority of organisms, further identification, extended antimicrobial susceptibility testing, and/or confirmation of resistance mechanisms is required, which are commonly performed by reference laboratories. Such laboratories also perform molecular typing to assist epidemiologic investigations and public health surveillance, although current typing methods often lack sufficient resolution to allow accurate inferences regarding transmission events.
2-11 Ideally, surveillance should be a dynamic process in which the flow of relevant information is monitored for a range of purposes, including the emergence of clinically significant drug resistance and detection of outbreaks.
8 Currently, this information is gathered retrospectively, usually in response to an outbreak, and can fail to have an impact on disease control, as demonstrated by the recent
Escherichia coli O104:H4 outbreak in Germany.
12